Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in Pediatric Radiology
- Vol. 18 (2) , 149-153
- https://doi.org/10.1007/bf02387559
Abstract
Two neonates with complex cyanotic congenital heart disease, receiving long-term prostaglandin E1 infusion, for 59 and 78 days respectively, demonstrated significant radiographic changes of symmetric cortical hyperostosis of the long bones. Bone biopsies from one of the patients elucidated the histological changes and serial X-rays revealed regression of the hyperostosis. Long-term follow-up after 13 months did not reveal any late bony changes or growth disturbance.This publication has 12 references indexed in Scilit:
- Effects of exogenous prostanoids on the proliferation of osteoblast-like cells in vitroProstaglandins, 1985
- Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.Archives of Disease in Childhood, 1985
- Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infantsThe Journal of Pediatrics, 1984
- Long-term low-dose prostaglandin E1 administrationThe Journal of Pediatrics, 1980
- Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart diseaseThe Journal of Pediatrics, 1980
- Long-term low-dose prostaglandin E1 administrationThe Journal of Pediatrics, 1980
- ORAL PROSTAGLANDIN E2 IN PULMONARY ATRESIAThe Lancet, 1979
- Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation, 1977
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975